
Strategic business and operations leader with 14+ years of experience driving enterprise initiatives across biotechnology organizations supporting biologics, oncology, rare diseases, vaccines, dermatology, neuroscience, and cell & gene therapies. Proven success leading cross-functional programs, implementing AI-enabled operational improvements, managing external partners, improving business processes, and translating complex scientific information into strategic business outcomes. Known for building consensus across executive leadership, R&D, Commercial, Manufacturing, Clinical Development, Regulatory Affairs, Supply Chain, Quality, and Operations teams.